SLC1A2 and Huntington disease: At early stages of the disease deficits in Kir4.1 and Glt1 (EAAT2) could contribute to underlying HD pathological mechanisms, which could further facilitate the progressive increase in astrocyte reactivity observed with disease progression in humans.